Prediction for glycemic variability in patients treated with insulin glargine 300 U/ml on basal insulin therapy

Prediction for glycemic variability in patients treated with insulin glargine 300 U/ml on basal insulin therapy - Prediction for glycemic variability in insulin glargine 300 U/ml

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039437

Enrollment

Registered

2020-02-08

Start date

2020-02-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with type 2 diabetes treated with insulin glargine 300 U/ml on basal insulin therapy during hospitalization

Exclusion criteria

Exclusion criteria: judged to be unsuitable for participation for medical reasons

Design outcomes

Primary

Measure	Time frame
A time and a cutoff value which can the most exactly predict TIR(70 to 180 mg/dL) < 70 percent	—

Secondary

Measure	Time frame
Times which the most correlate to CV or TBR(< 70 mg/dL) Times and cutoff values which can the most exactly predict CV > 36 percent or TBR(< 70 mg/dL)< 4 percent Times during daytime where differences between two glucose levels the most correlate to CV or TBR(< 70 mg/dL) Times during daytime where differences between two glucose levels can the most exactly predict CV > 36 percent or TBR(< 70 mg/dL)< 4 percent and those cutoff values	—

Measure

Time frame

Times which the most correlate to CV or TBR(< 70 mg/dL) Times and cutoff values which can the most exactly predict CV > 36 percent or TBR(< 70 mg/dL)< 4 percent Times during daytime where differences between two glucose levels the most correlate to CV or TBR(< 70 mg/dL) Times during daytime where differences between two glucose levels can the most exactly predict CV > 36 percent or TBR(< 70 mg/dL)< 4 percent and those cutoff values

—

Countries

Japan

Contacts

Public ContactSoichi Takeishi

Inuyama Chuo General Hospital Diabetes

souichi19811225@yahoo.co.jp0568-62-8111

Outcome results